Liver Failure/Cirrhosis/Portal Hypertension

You have full text access to this OnlineOpen article

Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation†

  1. Alexander Dechêne1,
  2. Jan-Peter Sowa1,
  3. Robert K. Gieseler1,4,
  4. Christoph Jochum1,
  5. Lars P. Bechmann1,5,
  6. Amr El Fouly1,
  7. Martin Schlattjan1,
  8. Fuat Saner2,
  9. Hideo A. Baba3,
  10. Andreas Paul2,
  11. Volker Dries6,
  12. Margarethe Odenthal7,
  13. Guido Gerken1,
  14. Scott L. Friedman5,
  15. Ali Canbay1,‡,*

Article first published online: 14 MAY 2010

DOI: 10.1002/hep.23754

Issue

Hepatology

Hepatology

Volume 52, Issue 3, pages 1008–1016, September 2010

Additional Information

How to Cite

Dechêne, A., Sowa, J.-P., Gieseler, R. K., Jochum, C., Bechmann, L. P., El Fouly, A., Schlattjan, M., Saner, F., Baba, H. A., Paul, A., Dries, V., Odenthal, M., Gerken, G., Friedman, S. L. and Canbay, A. (2010), Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology, 52: 1008–1016. doi: 10.1002/hep.23754

Author Information

  1. 1

    Department of Gastroenterology and Hepatology, Essen, Germany

  2. 2

    Department of General, Visceral, and Transplantation Surgery, Essen, Germany

  3. 3

    Institute for Pathology and Neuropathology, University Hospital Essen, Essen, Germany

  4. 4

    Division of Research and Development, Rodos BioTarget, Medical Park Hannover, Hannover, Germany

  5. 5

    Department of Liver Diseases, Mount Sinai School of Medicine, New York, NY

  6. 6

    Institute of Pathology, Mannheim, Germany

  7. 7

    Institute of Pathology, University Hospital Cologne, Cologne, Germany

  1. ‡

    fax: +49 (201) 723-5719

*Department of Gastroenterology and Hepatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 26 AUG 2010
  2. Article first published online: 14 MAY 2010
  3. Manuscript Accepted: 30 APR 2010
  4. Manuscript Received: 16 MAR 2010

Funded by

  • German Research Foundation. Grant Number: CA 267/6-1
  • Wilhelm Laupitz Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (557K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Hopper, W. Kemp, P. Porapakkham, Y. Sata, E. Condon, M. Skiba, L. Farber, P. Porapakkham, T. J. Williams, S. Menahem, S. Roberts, H. Krum, Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography, European Journal of Heart Failure, 2012, 14, 6, 621

    CrossRef

  2. 2
    Éric Bourbonnais, Valérie–Ann Raymond, Chantal Éthier, Bich N. Nguyen, Marc Saba El–Leil, Sylvain Meloche, Marc Bilodeau, Liver Fibrosis Protects Mice From Acute Hepatocellular Injury, Gastroenterology, 2012, 142, 1, 130

    CrossRef

  3. 3
    Jayashree Bagchi Chakraborty, Fiona Oakley, Meagan J. Walsh, Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  4. 4
    J. Hadem, A.S. Schneider, M.P. Manns, Akutes Leberversagen, Der Internist, 2011, 52, 7, 804

    CrossRef

  5. 5
    Dominique Thabut, Chittaranjan Routray, Gwen Lomberk, Uday Shergill, Kevin Glaser, Robert Huebert, Leena Patel, Tetyana Masyuk, Boris Blechacz, Andrew Vercnocke, Erik Ritman, Richard Ehman, Raul Urrutia, Vijay Shah, Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis, Hepatology, 2011, 54, 2
    Direct Link:
  6. 6
    Norifumi Kawada, Evolution of hepatic fibrosis research, Hepatology Research, 2011, 41, 3
    Direct Link:
  7. 7
    Alexander Koch, Andreas Horn, Hanna Dückers, Eray Yagmur, Edouard Sanson, Jan Bruensing, Lukas Buendgens, Sebastian Voigt, Christian Trautwein, Frank Tacke, Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU, Critical Care, 2011, 15, 6, R266

    CrossRef

  8. 8
    Xiao-dan Wang, Zu-hua Gao, Xia Xue, Yan-na Cheng, Pan Yue, Xu-wen Fang, Xian-jun Qu, N1-acetyl substituted pyrrolidine derivative CIP-A5: A novel compound that could ameliorate liver cirrhosis through modulation of hepatic stellate cell activity, Toxicology in Vitro, 2011, 25, 4, 897

    CrossRef

  9. 9
    Hua Wang, Fouad Lafdil, Lei Wang, Shi Yin, Dechun Feng, Bin Gao, Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production, Cell & Bioscience, 2011, 1, 1, 14

    CrossRef

View Full Article with Supporting Information (HTML) Get PDF (557K)